Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
about
The TGF-β/Smad repressor TG-interacting factor 1 (TGIF1) plays a role in radiation-induced intestinal injury independently of a Smad signaling pathwayGaining insight into the inhibition of glycoside hydrolase family 20 exo-β-N-acetylhexosaminidases using a structural approachMultiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosisIncreased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockadeDifferential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell linesNear infrared imaging of EGFR of oral squamous cell carcinoma in mice administered arsenic trioxidePost-transcriptional controls by ribonucleoprotein complexes in the acquisition of drug resistance.Elevated expression of TGIF is involved in lung carcinogenesis.Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.TG-interacting factor mediates arsenic-induced malignant transformation of keratinocytes via c-Src/EGFR/AKT/FOXO3A and redox signalings.Arsenic trioxide induces G2/M arrest in hepatocellular carcinoma cells by increasing the tumor suppressor PTEN expression.Knockdown of TGIF attenuates the proliferation and tumorigenicity of EC109 cells and promotes cisplatin-induced apoptosis.Silencing of TGIF sensitizes MDA-MB-231 human breast cancer cells to cisplatin-induced apoptosis.Arsenite inhibits the function of CD133+ CD13+ liver cancer stem cells by reducing PML and Oct4 protein expression.Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma.
P2860
Q27303974-4E2644F4-5610-4465-AB1D-FF7D9BBB02EFQ27677503-D99071B0-4913-4E4B-B184-E4E6E3DB249FQ28290458-7A34736B-5FA4-4003-B133-54770F5D3A03Q28539684-D3D7AC22-F32D-4FA6-BD38-1AC613817B47Q34410337-0FA70169-4C84-478E-80A7-177DC0050890Q34430979-E07CF941-957F-43BA-814B-6746E5236390Q37139289-BD46284F-0F0F-484B-A3C2-2ACF61939F59Q38862120-770036E7-81CD-49E0-90F5-2E668FF44D27Q38904143-723F3C43-3AFA-4FC5-82CF-CE029A045F24Q38925730-06157EE5-43CF-4A31-848D-FD2661EF731BQ39325807-AD27CC81-C484-4F43-AA8B-42B934351357Q49419196-85C9B163-2F57-4FFD-A8BF-B8B9F2CA2328Q49875247-E0B5962F-7600-4873-9A7A-A6FF35E85DECQ51575389-1F540E19-A3FD-47C8-9BA2-FE3B082A8B87Q53482041-FB90F6A5-CE54-4341-B897-DFB4AA090DAE
P2860
Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Suppression of TG-interacting ...... epatocellular carcinoma cells.
@en
Suppression of TG-interacting ...... epatocellular carcinoma cells.
@nl
type
label
Suppression of TG-interacting ...... epatocellular carcinoma cells.
@en
Suppression of TG-interacting ...... epatocellular carcinoma cells.
@nl
prefLabel
Suppression of TG-interacting ...... epatocellular carcinoma cells.
@en
Suppression of TG-interacting ...... epatocellular carcinoma cells.
@nl
P2093
P2860
P356
P1433
P1476
Suppression of TG-interacting ...... hepatocellular carcinoma cells
@en
P2093
Duang-Yang Hong
Huei-Sheng Huang
Zi-Miao Liu
P2860
P304
P356
10.1042/BJ20101653
P407
P577
2011-09-01T00:00:00Z